| scholarly article | Q13442814 |
| P50 | author | Ivan Bieche | Q56419632 |
| P2093 | author name string | R Lidereau | |
| F Spyratos | |||
| J M Guinebretière | |||
| E Rouleau | |||
| B Dieumegard | |||
| P2860 | cites work | KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. | Q27851422 |
| Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer | Q28271324 | ||
| K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study | Q38452428 | ||
| Characterization of a novel oncogenic K-ras mutation in colon cancer | Q57739525 | ||
| High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer | Q81643198 | ||
| KRAS mutation profile in colorectal carcinoma and novel mutation--internal tandem duplication in KRAS | Q81723295 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 2100 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition | |
| P478 | volume | 99 |
| Q37396252 | A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting |
| Q39416581 | Differences in the frequencies of K-ras c12-13 genotypes by gender and pathologic phenotypes in colorectal tumors measured using the allele discrimination method |
| Q39431960 | Novel EGFR-TK inhibitor EKB-569 inhibits hepatocellular carcinoma cell proliferation by AKT and MAPK pathways |
| Q50929302 | Tumour molecular profiling for deciding therapy-the French initiative. |
Search more.